...
【24h】

Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability

机译:Z-ligustilide与羟丙基-β-环糊精的络合以提高稳定性和口服生物利用度

获取原文
获取原文并翻译 | 示例
           

摘要

To improve the stability and oral bioavailability of Z-ligustilide (LIG), the inclusion complex of LIG with hydroxypropyl-β-cyclodextrin (HP-β-CD) was prepared by the kneading method and characterized by UV-Vis spectroscopy, differential thermal analysis (DTA) and Fourier transform infrared (FTIR) spectroscopy. LIG is capable of forming an inclusion complex with HP-β-CD and the stoichiometry of the complex was 1:1. Stability of the inclusion complex against temperature and light was greatly enhanced compared to that of free LIG. Further, oral bioavailability of LIG and the inclusion complex in rats were studied and the plasma drug concentration-time curves fitted well with the non-compartment model to estimate the absolute bioavailability, which was 7.5 and 35.9 %, respectively. In conclusion, these results show that LIG/HP-β-CD complexation can be of great use for increasing the stability and biological efficacy of LIG.
机译:为了提高Z-ligustilide(LIG)的稳定性和口服生物利用度,通过捏合方法制备了LIG与羟丙基-β-环糊精(HP-β-CD)的包合物,并通过紫外-可见光谱,差热分析对其进行了表征。 (DTA)和傅立叶变换红外(FTIR)光谱。 LIG能够与HP-β-CD形成包合物,该化合物的化学计量比为1:1。与游离LIG相比,包合物对温度和光的稳定性大大提高。此外,研究了大鼠LIG和包合物的口服生物利用度,血浆药物浓度-时间曲线与非房室模型拟合得很好,估计绝对生物利用度分别为7.5%和35.9%。综上所述,这些结果表明LIG /HP-β-CD络合物对于提高LIG的稳定性和生物学功效具有重要的用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号